13F
中

NHC NATIONAL HEALTHCARE CORP

2026Q1 · CUSIP 635906100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
236
Δ holders QoQ
+15
Breadth percentile
Top 21%
Whale holders
118
Δ whales
+3
Inst. holding value
$1.6B
New positions
46
Closed positions
31
Price momentum (1Q)
+19.5%
Put / Call
0/1

Breadth history (34 quarters)

2018Q1: Δ+5 · h=123 2018Q2: Δ-5 · h=118 2018Q3: Δ+4 · h=122 2018Q4: Δ+6 · h=128 2019Q1: Δ+0 · h=128 2019Q2: Δ+4 · h=132 2019Q3: Δ+6 · h=138 2019Q4: Δ+11 · h=149 2020Q1: Δ-4 · h=145 2020Q2: Δ-7 · h=138 2020Q3: Δ-11 · h=127 2020Q4: Δ+4 · h=131 2021Q1: Δ-1 · h=130 2021Q2: Δ+9 · h=139 2021Q3: Δ-10 · h=129 2021Q4: Δ+0 · h=129 2022Q1: Δ-8 · h=121 2022Q2: Δ-1 · h=120 2022Q3: Δ+6 · h=126 2022Q4: Δ-7 · h=119 2023Q1: Δ+18 · h=137 2023Q2: Δ-4 · h=133 2023Q3: Δ+0 · h=133 2023Q4: Δ+28 · h=161 2024Q1: Δ+11 · h=172 2024Q2: Δ+4 · h=176 2024Q3: Δ+19 · h=195 2024Q4: Δ-6 · h=189 2025Q1: Δ-8 · h=181 2025Q2: Δ+12 · h=193 2025Q3: Δ+15 · h=208 2025Q4: Δ+13 · h=221 2026Q1: Δ+15 · h=236 2018Q1: holders=123 2018Q2: holders=118 2018Q3: holders=122 2018Q4: holders=128 2019Q1: holders=128 2019Q2: holders=132 2019Q3: holders=138 2019Q4: holders=149 2020Q1: holders=145 2020Q2: holders=138 2020Q3: holders=127 2020Q4: holders=131 2021Q1: holders=130 2021Q2: holders=139 2021Q3: holders=129 2021Q4: holders=129 2022Q1: holders=121 2022Q2: holders=120 2022Q3: holders=126 2022Q4: holders=119 2023Q1: holders=137 2023Q2: holders=133 2023Q3: holders=133 2023Q4: holders=161 2024Q1: holders=172 2024Q2: holders=176 2024Q3: holders=195 2024Q4: holders=189 2025Q1: holders=181 2025Q2: holders=193 2025Q3: holders=208 2025Q4: holders=221 2026Q1: holders=236 -28 -14 +0 +14 +28 106177248 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q3 Top 18% -24.0% -17.0%
2023Q4 Top 19% +8.2% +38.4%
2023Q1 Top 9% +18.9% +29.6%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
1
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
26.4
EPS (TTM)
$7.87
EPS YoY
+13.9%
Revenue (TTM)
$1.5B
Revenue YoY
+10.3%
Quarterly Revenue & EPS (4Y)
2022-06-30: $271M 2022-09-30: $271M 2022-12-31: $265M 2023-03-31: $270M 2023-06-30: $283M 2023-09-30: $288M 2023-12-31: $301M 2024-03-31: $297M 2024-06-30: $301M 2024-09-30: $340M 2024-12-31: $369M 2025-03-31: $374M 2025-06-30: $375M 2025-09-30: $383M 2025-12-31: $387M 2026-03-31: $382M 2022-06-30: EPS 0.21 2022-09-30: EPS -0.16 2022-12-31: EPS 0.41 2023-03-31: EPS 0.76 2023-06-30: EPS 1.06 2023-09-30: EPS 0.68 2023-12-31: EPS 1.84 2024-03-31: EPS 1.69 2024-06-30: EPS 1.73 2024-09-30: EPS 2.73 2024-12-31: EPS 0.38 2025-03-31: EPS 2.07 2025-06-30: EPS 1.52 2025-09-30: EPS 2.50 2025-12-31: EPS 1.58 2026-03-31: EPS 2.27 0M 193M 387M $M -0.18 1.41 3.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 20 2023-03-31: PE 44.52023-06-30: PE 31.42023-09-30: PE 24.52023-12-31: PE 20.42024-03-31: PE 18.22024-06-30: PE 20.62024-09-30: PE 15.22024-12-31: PE 15.32025-03-31: PE 15.42025-06-30: PE 15.82025-09-30: PE 19.62025-12-31: PE 222026-03-31: PE 24.5 14 30 47 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)